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Abstract: Background and Objectives: Primary care physicians frequently prescribe antibiotics for
acutely ill children, even though they usually have self-limiting diseases of viral etiology. The
aim of this research was to evaluate the routine antibiotic-prescribing habits of primary care in
Latvia, in response to children presenting with infections. Materials and Methods: This cross-sectional
study included acutely ill children who consulted eighty family physicians (FP) in Latvia, between
November 2019 and May 2020. The data regarding patient demographics, diagnoses treated with
antibiotics, the choice of antibiotics and the use of diagnostic tests were collected. Results: The study
population comprised 2383 patients aged between one month and 17 years, presenting an acute
infection episode, who had a face-to-face consultation with an FP. Overall, 29.2% of these patients
received an antibiotic prescription. The diagnoses most often treated with antibiotics were otitis
(45.8% of all antibiotic prescriptions), acute bronchitis (25.0%) and the common cold (14.8%). The most
commonly prescribed antibiotics were amoxicillin (55.9% of prescriptions), amoxicillin/clavulanate
(18.1%) and clarithromycin (11.8%). Diagnostic tests were carried out for 59.6% of children presenting
with acute infections and preceded 66.4% of antibiotic prescriptions. Conclusion: Our data revealed
that a high level of antibiotic prescribing for self-limiting viral infections in children continues to
occur. The underuse of narrow-spectrum antibiotics and suboptimal use of diagnostic tests before
treatment decision-making were also identified. To achieve a more rational use of antibiotics in
primary care for children with a fever, professionals and parents need to be better educated on this
subject, and diagnostic tests should be used more extensively, including the implementation of daily
point-of-care testing.
Keywords: acute infections; children; antibiotic prescription; primary care; diagnostic test
1. Introduction
Acute illness in pediatric patients is a common reason for seeking the help of family
physicians (FP). However, in these circumstances, the children mostly have self-limiting
viral infections that do not require specific treatment.
Antibiotics are the most commonly administered prescription drugs for children [1],
around 90% of which are prescribed in primary care. Studies in European countries have
shown that more than 50% of children have received at least one course of antimicrobial
therapy before the age of one [2,3]. Of particular concern is the fact that the highest
antibiotic prescription rates are in the age group from two to five years old, as we know that
in this age group, viral infections dominate [4], and the use of broad-spectrum antibiotics
rather than narrow-spectrum ones is increasing [5]. A recent study has also shown that
broad-spectrum antibiotics are often prescribed as the first-choice therapy in Latvia, thus
contributing to the growing resistance to antibiotics [6].
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In pediatric populations, the most common reason for antibacterial treatment is upper
and lower respiratory tract infections [7]. However, despite the evidence showing little or
no benefit from antibiotic therapies, up to 80% of patients consulting primary care clinicians
for these complaints are still prescribed them [8,9].
Several factors contribute to the unwarranted and extensive use of antimicrobials in
children in primary care: incomplete clinical evaluation of children with a fever; a lack of
evidence-based decisions on the part of doctors; diagnostic uncertainty in differentiating
viral and bacterial infections, and a fear of missing serious bacterial infections; an extensive
phobia of fever amongst parents [9,10]. These factors also lead to unnecessary hospital
referrals, needless additional testing, and an increase in the number of potentially avoidable
short-stay hospital admissions for children [3].
Point-of-care testing (POCT), defined as medical diagnostic testing at or near the site of
patient care, is a fast and simple tool that can support clinical decision-making and improve
the quality of primary care for children [3]. For acute illnesses, POCT such as group A
streptococcal antigens, C-reactive protein level, urine strips and bacteriological cultures
may be useful and may suppress rushed antibiotic prescribing [8]. Therefore, the usage of
diagnostic tests has the potential to improve targeted antimicrobial treatment; however, in
Latvia, POCT usage before decision-making has been reported to be very low [6].
The unwarranted use of antibacterial therapies contributes to avoidable adverse ef-
fects, healthcare costs and the emergence of antibiotic resistance. Growing antimicrobial
resistance is a major problem in global healthcare and, consequently, a significant rational-
ization and reduction of antibiotic use is essential [5,11].
The aim of this research was to evaluate the routine antibiotic-prescribing habits of
primary care in Latvia, in response to children presenting with infections.
2. Materials and Methods
The cross-sectional study was conducted in Latvia between November 2019 and
May 2020. In order to evaluate the management of infectious diseases and the routine
prescribing of antibiotics for children in primary care in Latvia, 80 FP from various Latvian
regions were asked to record data on pediatric patients, aged from 1 month to 17 years, with
an acute infection episode, who attended consultations during face-to-face appointments.
There are about 360,000 children in Latvia and they are cared for by about 1300 FP, who are
self-employed and are usually located independently but, apart from these practitioners,
there are also 22 primary-care pediatricians.
2.1. Participating Children
Inclusion criteria:
• Current clinical signs of acute infection for less than five days;
• Aged one month up to 17 years old;
• Exclusion criteria:
• Aged under 1 month;
• Re-convalescent stage of infectious disease;
• Use of antimicrobial therapy before the time of the visit.
2.2. Sample Size Calculation
Table 1 details the sample-size calculation. The target group of the study is the
underage population of Latvia (0–17 years of age), visiting their FP due to an infectious
disease. The sampling method of the current study was according to their place of residence
and age-stratified convenience sampling, recruited via FPs. The sample size (column (f))
was calculated, taking into consideration the following criteria:
1. The total number of children aged 0–17 in 2019 (column (b)), according to the popula-
tion registry of Latvia [12];
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2. The proportion of children visiting FP within a year because of infectious diseases is
39% in children aged 0–4 years, and 8% in older ones [13] (respective calculated size
of the target population—column (c));
3. The time schedule of the research is 6 months (respective calculated size of the target
population—column (d));
4. The proportion of children receiving an antibiotic prescription in the case of an
infectious disease is on average 56% in the age group of 0–4 years, 23% in the age
group of 5–9 years, and 22% in the age groups of 10–14 years and 15–17 years [4,14,15]
(column (e));
5. The chosen confidence limit is ±5%.
Table 1. Size of the target population and the study sample.
Strata (a) Number ofInhabitants, Latvia (b)
Visiting FP







0–4 years Urban 56,072 21,868 10,934 56 366
Rural 70,412 27,461 13,730 56 369
5–9 years Urban 50,574 4046 2023 23 240
Rural 66,470 5318 2659 23 247
10–14 years Urban 50,408 4033 2016 22 234
Rural 69,916 5593 2797 22 242
15–17 years Urban 26,225 2098 1049 22 211
Rural 38,128 3050 1525 22 225
Total: 2134
Abbreviations: FP—family physician; AB—antibiotic.
2.3. Participating Family Physicians
The target group of the participating doctors was 1268 FP from the Latvian register
of family physicians. It was expected that each FP might see about 30 suitable patients
during the study. According to the sample size of 2134 patients, a total of 80 FP was
required. The participating doctors were recruited using two approaches. First, from
the 1268 FPs, through an Excel random-number generator, we selected 160 doctors (the
expected response rate was 50%) across different geographically located practices (urban
and rural areas) and sent invitations in both email and letter form to participate in the
study. The response rate was lower than expected, and we recruited only 38 participants
using this approach. Secondly, we directly addressed doctors at a meeting of the Latvian
Family Physicians Association and achieved the requisite number of 80 participants. Of
these 80 FP, 34 were located in the capital of Latvia, which was in proportion to the
distribution of the population within the country. The participating doctors were regularly
practicing physicians who were not normally involved in academic research. Doctors who
included fewer than five patients were excluded from the study. The data from 73 practices
were analyzed.
2.4. Data Collection
The data were collected in anonymized form, including patient demographics, di-
agnoses based on a pre-defined list, laboratory tests performed before the initiation of
antimicrobial treatment (such as a full blood count, C-reactive protein measurement from
venous blood samples or POCT from capillary blood, urine test strips and microscopy,
group A streptococcal rapid antigen testing, rapid influenza diagnostic tests, bacteriological
cultures, X-ray) and—in the case of antibiotic prescription—whether it was a delayed or
immediate antibiotic prescription and choice of antimicrobial group.
2.5. Statistical Analyses
Descriptive statistics, such as means (with standard deviations) and medians for
continuous variables, and the proportions for categorical variables, were calculated. The
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Kolmogorov–Smirnov test was used to test the normality of distribution. To evaluate the
statistical significance of the differences in proportions of dependent variables between
subgroups of independent variables, either the chi-square test or Fisher’s exact test was
used. Statistical significance was set at p = 0.05. Data processing was performed using IBM
SPSS Statistics (Statistical Package for the Social Sciences, Version 23.0).
The main outcome measure was antibiotic prescribing and the type of antibiotics.
The study was approved by the Ethics Committee of Riga Stradins University, ap-
proval no. 6-3/5/21 (30 May 2019).
3. Results
During the six-month study period, 2497 children with acute illnesses were enrolled.
In total, 2383 patients met the inclusion criteria, after 109 patients were excluded due to a
symptom duration of more than five days, and 5 patients were excluded because of missing
diagnoses (Figure 1).
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Figure 1. Flowchart of included family physicians (FP) and recruited illness episodes.
The mean number of included patients per FP was 29.8. The mean age was 6.1 years,
and t dia , 5.0 years. Boys comprised 50.1% of the study participants. T ble 2 d tails
the c aracteristics of the studied po ulation.
According to the physicians’ diagnoses, the most common infections observed were
the common cold (40.8%), otitis (32.6%), and acute bronchitis (15.8%). These diagnoses were
the ones most often treated with antibiotics; otitis was responsible for 45.8% of all antibiotic
prescriptions, acute bronchitis for 25.0%, and the common cold for 14.8%. Table 3 lists all
the diagnoses observed, the number of patients diagnosed with each type of infection, and
the number of patients receiving an antibiotic prescription (the distribution of diagnoses
treated with antibiotics is shown in parentheses). The proportion of patients treated with
antibiotics for each type of infection is shown in Figure 2.
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Table 2. Characteristics of the studied population and those patients treated with antibiotics.
Variable Study Population
Mean age (all patients, years) 6.1 (SD 4.3)
Age groups
0–4 years 1094 (45.9%)
5–9 years 743 (31.2%)
10–14 years 371 (15.6%)
15–17 years 140 (5.9%)




Missing information on gender 20 (0.8%)
Patients receiving an antibiotic prescription 697 (29.2%)
Mean age of patients who received an antibiotic (years) 5.8 (SD 4.4)
Table 3. Major types of infections for all recruited patients and patients treated with antibiotics.
Diagnosis Number of All Patients Number of Patients Receivingan Antibiotic Prescription
Common cold 973 (40.8%) 103 (14.8%)
Otitis 776 (32.6%) 319 (45.8%)
Rhinosinusitis 16 (0.7%) 5 (0.7%)
Pharyngotonsillitis 72 (3.0%) 17 (2.4%)
Other otorhinolaryngological (ORL) infection 14 (0.6%) 0 (0.0%)
Acute bronchitis 377 (15.8%) 174 (25.0%)
Pneumonia 72 (3.0%) 57 (8.2%)
Gastrointestinal infections 48 (2.0%) 2 (0.3%)
Urinary tract infections 29 (1.2%) 18 (2.6%)
Skin/soft tissue infections 5 (0.2%) 2 (0.3%)
Bone and joint infections 1 (0.0%) 0 (0.0%)
Total 2383 (100%) 697 (100%)
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received an antibiotic prescription, 28.0% in the age group of 5–9 years, 22.9% in the age
group of 10–14 years, and 34.3% in the age group of 15–17 years. The proportions of
antibiotic prescriptions in the different age groups were significantly different (p = 0.008),
particularly between the age groups of 0–4 years and 10–14 years (p = 0.002), and between
10–14 years and 15–17 years (p = 0.009).
Antibiotics were prescribed for 29.8% of the girls and for 28.8% of the boys. This
difference between the genders was not statistically significant (p = 0.59).
In total, 63.4% of patients were consulted on the second and third days of illness, and
more than half (61.6%) of antibiotic prescriptions occurred in this symptom duration range.
278 patients’ data were missing information on the duration of symptoms.
The proportions of antibiotic prescriptions in relation to the duration of symptoms are
presented in Table 4. The proportions of antibiotic prescriptions in the different durations
of symptoms groups were significantly different (p = 0.04), particularly between the 1st day
and the 3rd day (p = 0.047), the 2nd day and the 3rd day (p = 0.004), the 2nd day and the
4th day (p = 0.01) and the 2nd day and the 5th day (p = 0.02).
Table 4. Proportions of antibiotic (AB) prescriptions, relative to the duration of symptoms.
Duration of Symptoms
before Visit (Days) AB Prescribed AB Not Prescribed Total
1 23 (22.3%) 80 (77.7%) 103 (100.0%)
2 159 (24.8%) 482 (75.2%) 641 (100.0%)
3 222 (32.0%) 472 (68.0%) 694 (100.0%)
4 140 (31.8%) 300 (68.2%) 440 (100.0%)
5 74 (32.6%) 153 (67.4%) 227 (100.0%)
Total 618 (29.4%) 1487 (70.6%) 2105 (100%)
In total, 12 different antibiotics were prescribed. In almost all cases, the drugs were
administered per os. However, two patients received antibiotics intravenously after being
sent to the hospital, following their examination in primary care (one patient received
ampicillin J01CA01, and the other received ceftriaxone).
Penicillins represented 80.3% of all prescriptions for antibiotics and were the most
widely used drug in all the age groups. Specifically, 55.9% of administered penicillins
were extended-spectrum types, 18.1% were in combination with beta-lactamase inhibitors,
while just 6.1% were narrow-spectrum beta-lactamase-sensitive penicillins. Penicillins were
mostly prescribed for cases of acute otitis (50.6%), acute bronchitis (25.0%) and the common
cold (15.0%). Penicillins were followed by macrolides 12.6% (37.1% for pneumonia, 32.6%
for acute bronchitis and 18.0% for otitis) and cephalosporins 4.1% (44.8% for otitis, 17.2%
for acute bronchitis and 17.2% for pneumonia). Of the cephalosporins, 93.1% were second-
generation ones. Overall, the most commonly prescribed antibiotics were amoxicillin
(55.9% of prescriptions), amoxicillin/clavulanate (18.1%) and clarithromycin (11.8%).
Figure 3 illustrates the most common antibiotic groups according to patient age.
The proportions of prescribed antibiotic subgroups in the different age groups were not
significantly different (p = 0.57).
Laboratory or radiological investigations were carried out for 59.6% of the study
population and for 66.4% of the cases treated with antibiotics. However, all other deci-
sions of antibiotic prescribing were based only on clinical assessment, either due to the
unavailability of testing (12.3%) or because investigations were deemed to be unnecessary,
according to the doctor’s opinion (21.2%). The proportion of diagnostic testing prior to
antibiotic prescribing is indicated in Figure 4.
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performed at a significantly higher frequency in older children (p < 0.001): 70.7% in the
age group of 15–17 years; 57.1% in the age group of 10–14 years; 54.4% in the age group of
5–9 years; 48.0% in the age group of 0–4 years.
Although 23.6% (n = 20) of patients with pharyngotonsillitis were treated with antibi-
otics, only 2.8% (n = 2) of patients with this diagnosis were tested for group A streptococci.
X-ray imaging was used for 45.8% (n = 33) of patients with pneumonia, while dipstick urine
tests or urine analyses were used for 72.4% (n = 21) of patients with urinary tract infections.
4. Discussion
The purpose of this study was to determine the antibiotic-prescribing habits of primary
care in Latvia. Importantly, this is the first time that pediatric patients have been exclusively
analyzed. Studies on outpatient antibiotic treatment practices in Latvia have previously
been published by Dumpis et al. (2013 data from Latvia only [16], and 2018 data from
Latvia, Lithuania and Sweden, were compared [6]). However, these studies had patient
populations that included both children and adults.
Our data showed that 29.2% of pediatric patients with an acute illness episode, con-
sulting primary care, received an antibiotic prescription. This prescription rate is lower
than the ones reported by Dumpis et al. (42% in Latvia and Lithuania, 38% in Sweden).
Moreover, patients younger than 20 years of age comprised the majority of all patients
receiving antibiotics in Latvia (51%) and Lithuania (53%), while in Sweden this age group
comprised 33% [6].
We found that 5.5% of patients received a delayed antibiotic prescription. This is one
of the strategies to try and reduce antibiotic use for respiratory infections, and has been
reported to engender similar patient satisfaction to immediate antibiotic prescription [17].
However, many patients suffering from the common cold still expect to be prescribed an
antibiotic when visiting their FP [18].
The highest antibiotic prescription rates were observed in the age groups of 0–4 years
(31.4%) and 15–17 years (34.3%). Studies in other countries have shown a decline in the
prescription rate with increasing age, and that one-year-olds [2] and two- to five-year-
olds [4] had the highest rate of antibiotic use. In Germany and the Netherlands, children in
the 2–5 years age group and those older than 15 years were found to receive antibiotics
most often [18,19]
In this study, in order to focus on the early initiation of antibacterial treatment, only
patients with a symptom duration of under five days were analyzed. Dumpis et al.’s
2018 study analyzed patients with longer symptom duration—6.4 days in Latvia, 7.3 days
in Lithuania, and 11 days in Sweden. This suggests that, in Sweden, patients with viral
infections tend to be given symptomatic treatment at home for a longer period [6]. Almost
70% of our patients were consulted within the first three days of the onset of symptoms,
and a substantial amount of antibiotics was prescribed at the beginning of the illness
episodes. This trend for the early initiation of antibacterial treatment may be due to
several factors that have previously been described: difficulties differentiating viral from
bacterial infections [20]; overdiagnosis of certain conditions [21]; fear of missing serious
bacterial infections; parental insistence on antibiotics [22]. Interestingly, in low-prescribing
regions, there are no data that suggest worse outcomes for acute illness episodes due to
undertreatment [21].
4.1. Diagnoses Treated with Antibiotics
In line with other studies, we found that respiratory infections were the main indicator
for visiting the FP during acute illness episodes [16,23]. Although it is well known that
acute respiratory infections are predominantly of viral etiology and are self-limiting, in
countries other than Latvia, this type of infection also accounts for the majority of antibiotic
prescriptions [24].
Otitis, acute bronchitis and the common cold were the most common diagnoses treated
with antibiotics, responsible for about 85% of all antibiotics prescribed. Our data are in
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accordance with data collected in Germany and the Netherlands [18] where the most
frequent indications for antibiotic prescriptions for children were otitis media, tonsillitis,
other upper respiratory tract infections, and bronchitis (70–80% of antibiotic prescriptions).
A number of recent systematic reviews suggest that antibiotics only slightly modify the
course of otitis media, tonsillitis and bronchitis, and have no effect on the course of the
common cold [17].
We found a low antibiotic prescription rate for otitis (41.1%) compared with other
studies, for example, 56% in the Netherlands [25], and more than 90% in Ireland [23] and
the United States [26]. Additionally, we observed an antibiotic prescription rate of 46.2% for
acute bronchitis, whereas a lower rate has been reported in Sweden (21%) and higher rates
in Lithuania (68%), Latvia (72%; as published in Dumpis et al.’s 2018 study [6]), and Ireland
(84%) [23]. However, it should be noted that the pediatric population was not analyzed
separately in these studies. A relatively small number of patients who consulted their FP
received a diagnosis of pharyngotonsillitis in our study (n = 72, 3.0% of all episodes); the
prescription rate (23.6%) was lower than in other studies (53.11% for patients with a sore
throat and 94.87% with tonsillitis) [23].
4.2. Choice of Antibiotic
Broad-spectrum antibiotics are still being widely used in primary care [4]. In this
study, by far the most prescribed antibiotic class used in all four age groups was peni-
cillin, accounting for 80% of all antibiotics prescribed. This finding complies with the
majority of recommendations to use penicillin as the first-line therapy for most common
pediatric respiratory infections. Similar findings have been described in primary care in
the Netherlands [7]. Broad-spectrum penicillins accounted for the majority of penicillin
prescriptions, while just 6.1% were narrow-spectrum ones. This was also the case in an
earlier study conducted in Latvia [16], and this may be due to the limited availability
of phenoxymethylpenicillin in the country and/or, in contrast to other penicillins, its
non-inclusion in the list of reimbursed drugs for children.
Macrolides were the second most frequently prescribed antibiotics (12.6%). In agree-
ment with previous studies [4], they were utilized to the greatest extent in the age group
of 10–14 years (15.7%); however, no significant differences in their percentage usage were
observed among the four age groups.
In contrast to the relatively high use of macrolides, cephalosporins accounted for only
4% of prescriptions. Our data are consistent with those reported in 2018 by Dumpis et al. [6].
It has been observed that cephalosporins are the second most frequently consumed class
of antibiotics in Germany, with cefuroxime being the most often prescribed of this class,
whereas they have been noted to be very rarely used in the Netherlands, the United
Kingdom and Scandinavian countries [4,18].
The three most often used drugs in the study were amoxicillin, amoxicillin/clavulanate
and clarithromycin. Amoxicillin has been reported to be the leading antibiotic prescribed
in the Netherlands, Germany and Canada, with amoxicillin/clavulanate being the most
prescribed one in Italy and Ireland [18,23] and the second most frequently prescribed one in
the Netherlands [7]. Clarithromycin is widely used in many countries in Europe; however,
it belongs to the 2019 WHO AWaRe classification database’s “watch group” of antibiotics,
which have higher resistance potential.
4.3. Diagnostic Management before Antibiotic Prescribing
FP utilized diagnostic tools for only 66.4% of patients before prescribing antibiotics.
Accurate diagnostic testing has the potential to support clinical decision-making, reduce
the overtreatment of viral infections, and provide reassurance to physicians regarding
postponing immediate antibacterial treatment [20]. In 12.3% of instances of antibiotic
prescribing, the FP was uncertain of the nature of the patient’s illness and considered it nec-
essary to carry out additional diagnostic tests before deciding on their treatment. However,
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this was not possible, as the relevant tests were not available on the day of the patient’s
visit. It is likely that this situation increases the rate of empirical antibacterial treatment.
Measurement of the level of C-reactive protein was the most frequently performed
diagnostic test in our study (53.0% of patients). This is in line with data from Sweden,
showing that this test is performed for about 50% of patients with respiratory infections.
In most Scandinavian countries, Germany, and Switzerland, it is widely available as a
POCT [27,28]. However, in Latvia, a POCT of the level of C-reactive protein is available in
only a few medical practices, and so most of the analyses requested by FP continue to be
conducted in central laboratories. This situation hinders clinical decision-making, as the FP
receives the test results after their patient’s visit, possibly leading to overtreatment or extra
visits. POCT in ambulatory care has other benefits over laboratory testing: it is easy to use
and more child-friendly, as a finger prick-test is less invasive than a venous puncture; it
provides timely results, allowing treatment to be appropriately adapted during the patient’s
visit and giving the FP more confidence to withhold unnecessary treatment (which, in turn,
manages parents’ expectations for antibiotics and improves their satisfaction) [3,29–32].
With respect to respiratory infections, the combination of POCT of the level of C-
reactive protein and clinical assessment has been shown to have a significant effect on
antibiotic prescribing. For instance, an approximately 30% reduction in the prescription
rate has been reported. However, the data have mostly been derived from adult popula-
tions [28], and the value of testing for the management of children with acute infections
remains unconvincing [3]. Nevertheless, promising results have been seen in studies where
the usage of POCT for C-reactive protein levels and training in communications skills [9],
safety-net advice for parents [20], and FP educational interventions, were combined [33].
It is important to point out that this study has several limitations. The FP response
rate was lower than expected in random selection, and FPs included in the study may
have been more active and willing to avoid antibiotic prescribing. Patient inclusion was
distributed over a six-month period, and was not inclusive of all patients visiting their FP.
We did not reach the sample size for children older than 10 years, as they visited their FP
less often due to respiratory infections and were often at a later stage of the disease [19].
The rate of patient recruitment was slower than anticipated, due to a reduced number
of acute illness episodes in FP practices in the spring of 2020, as a consequence of SARS-
CoV-2 virus (COVID-19) epidemiological safety measures. One strength of our study is
the involvement of various FP practices from different geographical locations and the
availability of laboratory testing, which could potentially be found to have an impact on
antibiotic-prescribing habits.
5. Conclusions
Our results demonstrate that a high level of antibiotic prescribing for self-limiting
viral infections in children still exists, that narrow-spectrum antibiotics are underused, and
that there is a suboptimal use of diagnostic tests prior to treatment decision-making.
To achieve a more rational use of antibiotics in primary care for children with a fever,
professionals and parents need to be better educated on this subject, and diagnostic tests
should be used more extensively, including a greater implementation of daily point-of-
care testing.
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